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ABSTRACT
Objectives: Maintaining the quality of the pharmaceutical drug product during its shelf life is highly desirable. The crystalline form of the drug 
having the great thermodynamic stability is essential for the manufacturers in pharmaceutical industry in view of their profit and also for the safety 
of the customer. Many pharmaceutical drugs have the tendency to exhibit polymorphism which is unwanted for pharmaceutical companies, where 
they have experienced market shortages due to these unpredicted polymorphic and/or pseudomorphic changes. The property of a drug exhibiting 
more than one crystal form is considerably regarded as polymorphism and each of the crystalline form has its own physicochemical properties, 
namely, solubility, heat capacity, melting point, and sublimation point. To relieve this ultimate effect on the drug quality and stability, a prior detection 
of polymorphism in the final dosage form is highly recommended. Hence, many analytical techniques have been proposed for the detection of 
polymorphism in pharmaceutical drug products.
Methods: Fourier transform (FT)-Raman spectrometer is used for the investigation of drug polymorphism and the instrument is advanced with 
charge coupled device detectors, ease of sample preparation and handling, mitigation of sub-sampling problems using different geometric laser 
irradiance patterns and having different optical components of Raman spectrometers.
Results: In this work, we carefully studied the Raman spectral patterns for Lamivudine as well as Finasteride drug substances for the detection of 
polymorphism. Further, we have highlighted the advantages of FT-Raman spectroscopy over other polymorphism detection techniques. For example, 
Raman spectra showed invariably sharp, well resolved bands compare to IR spectra due to the minor contribution of overtone vibrations in Raman 
spectra, resulting in much less broadening and a better resolution of bands. Besides, Raman spectroscopy does not suffer from the sampling problems 
that are common in X-ray powder diffraction, where preferred orientation and specimen displacements are serious restrictions for the application of 
quantitative method.
Conclusion: Here, in this paper, we are presented and compared the experimental results regarding the detection of polymorphism in Lamivudine and 
Finasteride drugs using FT-Raman spectroscopy, to illustrate the advantages of the technique in the detection of polymorphism over other techniques.
Keywords: Polymorphism, Comparison, Finasteride, Lamivudine, Fourier Transform-Raman spectroscopy.
INTRODUCTION
Commercialization of pharmaceutical products involves a lengthy and 
time consuming process because (i) the product has to be tested for its 
suitability toward the target application, (ii) safety, (iii) efficacy, and (iv) 
need to conduct customer satisfaction survey [1]. However, this can be 
done through the study and investigation of raw drug materials, drug 
intermediates, final products, formulations, impurities, degradation 
products, and biological samples containing drugs and their 
metabolites to know the physicochemical properties even after their 
post-marketing [2]. Therefore, it is envisaged that proper corrective 
action should be needed at any phase of the study process to promote 
its safety and efficacy. Prominently, such investigation discloses the 
(i) effect of excipients on the drug formulation, (ii) incompatibility 
between excipient and drug, (iii) suitability of the excipient over drug 
administration to release the exact active component in the body, and 
(iv) capability of excipients in stabilizing the drug against degradation 
due to environmental factors [3].
Further, it is anticipated that, the research on discovery of new 
drugs are being lowering in recent days and the researchers and 
pharmaceutical companies are majorly focusing in preparation of 
drug modifications including active pharmaceutical ingredients 
(APIs), targeted to furnish the pharmacological activity with optimum 
therapeutic efficacy [4]. Evidently, it is important to mention here 
that nearly 40% of approved drugs and 90% of pipeline drugs are 
medications with poor solubility [5]. As an important property in view 
of pharmacological activity, drug molecules exhibited nearly 100–1000 
times solubility, whereas cocrystals and polymorphs exhibited 4–20 
times and 2–3 times, respectively. In addition, the solubility leads to 
the salt formation; a three component system consisted with acid, base, 
and solvent. However, the easiest approach to modify the properties 
of parent drug is salt formation where the unenviable features are 
conquered with ionizable functional groups. Cocrystals and APIs 
are non-ionizable neutral drugs, restricted with salt formation but 
fortunately the engineering of intermolecular interactions resulted 
in the generation of desired properties [6]. The solid drug substance 
that can be able to exist in more than one crystalline phase with 
various packing arrangements or molecular conformations in the same 
molecular species is considered as polymorphism [7]. It is estimated 
that, more than 50% of drugs exhibited polymorphism depending 
on the environmental conditions, and each form can significantly 
exhibited distinct physicochemical properties such as solubility, heat 
capacity, melting point, and sublimation point. Consequently, critical 
investigation on polymorphism of pharmaceutical solids during the 
pharmaceutical unit operations is worthful to alter the stability and 
bioavailability of the final drug product. Hence, it is recommended that 
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proper monitoring of different solid-state forms and understanding the 
drug interactions with water gains paramount importance to ensure 
the high-quality product [8].
Different analytical techniques were reported in the literature to measure 
the structural differences of the solid pharmaceuticals such as X-ray 
diffraction, kinetic techniques, gravimetric, volumetric, electrochemical, 
spectroscopic, and various separation techniques [9-14]. Among 
various spectroscopic techniques, Raman spectroscopy has gained 
much attention and widely used technique for the identification 
of polymorphs due to non-invasiveness, small amount of sample 
requirements, and specificity. Besides, this technique is able to identify 
various physical forms of medicine such as liquid, powder, cream, tablet, 
and ointment, but is not useful for some medicines as they do not show 
Raman scattering. Inspired by this, here in this paper, we are compared 
the experimental results studied for the detection of polymorphism 
in Lamivudine and Finasteride drugs using Fourier transform (FT)-
Raman spectroscopy, to illustrate the advantages of the technique 
in the detection of polymorphism over other techniques. The IUPAC 
name of the Lamivudine (Fig. 1) is [cis-4-amino-1-(2-hydroxymethyl-
1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one], which is a 1,3-oxathiolane 
nucleoside analog having antiviral activity and exists in at least two 
polymorphic forms. This drug is used in the medication to treat the HIV-
positive and hepatitis B-positive patients. The two polymeric forms are 
needle-shaped crystals (Form I) and bipyramidal crystals (Form II) [15]. 
Similarly, Finasteride (Fig. 1) supplied under the trade name PROSCAR 
and the IUPAC name is 17β-(n-tert-butyl-carbamyl)-4-aza-5α-androst-
1-en-3-one. It is a 5α-reductase inhibitor used in the treatment of acne, 
female hirsutism, and prostatic hyperplasia. Finasteride also exhibited 
two polymorphic forms in which the orthorhombic crystal structure is 
Form I and the monoclinic crystal structure is Form II [16].
METHODS
The pure crystalline polymorphic forms of Lamivudine (Form I and 
Form II) and Finasteride (Form I and Form II) drugs were synthesized 
in APL Research Centre, Aurobindo Pharma Limited, Hyderabad, India.
Preparation of polymorphic mixtures
Initially, the pure forms of Lamivudine and Finasteride drugs were 
ground with the help of porcelain mortar and pestle. Later, polymorphic 
mixtures of Form I and Form II for both Lamivudine and Finasteride 
drugs were prepared with different weight ratios for the study [15,16]. 
In addition to the test sample, calibration standards were also prepared 
to compare the results and it was observed from the FT-IR data that the 
grinding process does not induce the polymorphism.
Instrumentation
Polymorphism in Finasteride drug was investigated using NXR FT-
Raman spectrophotometer, Thermoelectron Corporation, USA, with the 
slit aperture of l50 mm and the laser power of l.0 W. The CaF2 crystal 
as beam splitter with InGaAs detector with a 180-degree reflective 
configuration for sample position adjustment was used. A total of 
512 scans at resolution of 4 cm-1 were acquired for each of standards 
and samples. Similarly for Lamivudine drug, Thermo Nicolet 5700 
NXR-FT Raman spectrometer equipped with Nd-YAG laser source at a 
wavelength of 1064 nm was used. The InGaAs detector with 150 scans 
at 0.7 w exciting power and 4 cm-1 spectral resolution and the scans 
were collected between 4000 and 200 cm-1. In addition, polarized light 
microscopy, FT-IR spectroscopy, differential scanning calorimeter, 
thermo gravimetric analysis, and X-ray powder diffraction studies were 
performed to further evidence the FT-Raman spectroscopic results.
Preparation of sample for Raman spectroscopy
A powdered sample was placed in a sample holder and it was a gold 
coated round shape central cavity and the cavity extended to other side 
of the holder. The holder was kept in such a way that the top face was 
placed over the stainless steel base and nearly 30 mg of the sample was 
poured into the cavity. The sample was gently pressed with the finger 
press and was placed in the mount holds, which holds the sample at 
the correct height in the sample compartment. For tablet samples, the 
tablet was cut with a razor blade and placed in a spring action clamp 
holder in the sample compartment [15,16].
RESULTS
To ensure that, the Raman spectroscopy is one of the best experimental 
techniques in detection and identification of polymorphic forms in 
drug substances and here, in this paper, we compared the Raman 
spectroscopic experimental results of Lamivudine and Finasteride 
drugs [15,16]. First of all, reference standards for Form I and Form II 
polymorphs of Lamivudine were thoroughly characterized by FT-IR 
spectroscopy, differential scanning calorimeter, thermo gravimetric 
analysis, and X-ray powder diffraction studies including Raman 
spectroscopy and confirmed that the purity of the polymorphs were 
100%. Raman spectrum of Form I showed a characteristic peak at 
697 cm-1 and showed no peak at 463 and 798 cm-1 which further 
confirms the absence of Form II (Fig. 2).
Later, the drug mixture containing 6 % (w/w) was analyzed by 
grinding at various time intervals, that is, 5, 10, 15, and 30 min to test 
the effect of grinding on polymorphism and was characterized by FT-
Raman spectroscopy. As shown in Fig. 3, all the above ground samples 
of different time intervals show the same peak intensity at 798 cm-1 
Raman shift which confirmed that the grinding process does not induce 
polymorphic conversion for both polymorphic forms as well as for the 
mixture containing 6% (w/w) of Form II in Form I. Therefore, there is 
no effect of grinding for the ground samples of polymorph standard 
mixtures, which were prepared with the help of porcelain mortar and 
pestle [15].
Again, FT-Raman spectra of both Form I, Form II, and mixture 
containing 4% (w/w) of Form II were studied. The spectra showed 
different pattern, and observed a Raman band particularly at 798 cm-1 
characteristic of Form II in polymorphic mixture containing 4% (w/w) 
of Form II in Form I (Fig. 4).
In continuation, FT-Raman analysis was performed for the two 
polymorphic forms of Finasteride, as shown in Fig. 5, which divulges 
that the Raman shifts between the two polymorphic forms were clearly 
distinguishable. The Raman spectra of Finasteride Form I and Form II 
tablets prepared at APL and the Raman spectra of the placebo were 
Fig. 1: Structure of lamivudine and Finasteride drugs
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recorded (Fig. 6). The two polymorph forms showed a clear remarkable 
difference in the Raman shift region between l750 and l550 cm-1. It 
was observed that no placebo interference was noticed in this region 
and therefore this region is suitable for identification and detection of 
Fig. 2: Collation of lamivudine Forms I and II with Fourier-transform-Raman spectra
Fig. 3: Collation of lamivudine forms I and II and ground samples at various time intervals containing 6% Form II with Fourier-transform-
Raman spectra
Fig. 4: Collation of Fourier-transform-Raman spectra of lamivudine forms I and II and 4% (w/w) Form II
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the polymorphic forms of Finasteride in the tablets. The characteristic 
peaks of the polymorphic Form I were present at 1670 and l695 cm-1, 
and for polymorphic Form II at nearly l656 and 1677 cm-1. The Raman 
spectral peak at l598 cm-1 was common for Finasteride polymorphic 
forms and was clearly indicated that there was no interference 
from placebo in the region between l750 and l550 cm-1. The major 
characteristic peak of the polymorphic Form I was observed nearly at 
l670 cm-1 and the minor peak nearly at l695 cm-1. The major peak is 
used for detection of the polymorph Form I in Form II tablets. In the 
same way, the major characteristic peak of polymorphic Form II was 
observed at l656 cm-1 and the minor peak at l677 cm-1, simultaneously 
the major peak of Form II was used for detection of the polymorph 
Form II in Form I tablets [16].
After studying above Raman spectral patterns, FT-Raman spectroscopy 
was finalized for the quantification of Lamivudine as well as Finasteride 
drug substances, and the method was developed by the preparation of 
polymorphic mixtures. The advantages of Raman spectroscopy over 
other analytical techniques are (i) very little sample is required for 
analysis, (ii) ease of sample preparation, which includes the fact that 
Fig. 6: Raman spectra of Finasteride polymorph Form I, Form II, and placebo in the quantification region
Fig. 5: Raman spectra of Finasteride polymorph Form I and Form II
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both glass and water show very little Raman scattering, (iii) Raman 
spectra showed invariably sharp, well resolved bands compare to IR 
spectra due to the minor contribution of overtone vibrations in Raman 
spectra, resulting in much less broadening and a better resolution of 
bands compared to IR spectra [17], and (iv) Raman spectroscopy does 
not suffer from the sampling problems that are common in X-ray powder 
diffraction, where preferred orientation and specimen displacements 
are serious restrictions for the application of quantitative method [18].
DISCUSSION
The existence of the drugs in more than one solid form is termed as 
polymorphism, which could become one of the hot research focus in 
recent days to investigate the most stable and effective form of drug 
material for its quality assurance. Among several techniques, FT-Raman 
spectroscopy method is the best one for the detection of polymorphism 
in medicines and here we compared the results obtained for Lamivudine 
and Finasteride drugs [15,16]. Initially, X-ray powder diffractometry 
(XRPD) technique was used for the study, as it requires small quantity of 
drug sample and the sample is non-destructive during the identification 
and quantification of polymorphic forms. However, the technique has 
the limitation for unwanted polymorphic forms, as it do not exhibit 
distinct X-ray powder pattern and more intense characteristic peaks of 
unwanted polymorphic form of drug substance. In case of Lamivudine 
polymorphic forms, Form II was not having the distinct X-ray powder 
pattern and is not having the interference free regions, so it is difficult 
to quantify the Form II with low limit of detection by XRPD. Since, it is 
difficult to quantify the unwanted form with low limit of detection by 
XRPD [15].
Similarly, IR spectra of lamivudine forms I and II are well correlated 
with the previously published spectra and it was observed that 
polymorphic Form I exhibits a strong absorption band, but no bands 
were observed for polymorphic Form II [16]. Differential scanning 
calorimetry thermograms disclosed that the melting and crystallization 
temperature values of polymorphic forms of Lamivudine were different. 
As an advanced analytical method, FT-Raman spectroscopy has the 
advantage of direct investigation of solid samples without sample 
preparation. On investigation, Raman spectrum of Lamivudine Form 
I shows characteristic peak at 697 cm-1, as shown in Fig. 2. However, 
there were no such peaks observed at 463 and 798 cm-1 indicates the 
absence of Lamivudine Form II. Later, to reduce the source of error 
occurred due to the heterogeneity of the sample, pure polymorphic 
forms were ground in a porcelain mortar with the help of pestle for 
5 min and were characterized by FT-Raman spectroscopy to identify the 
affect of grinding for polymorphic changes of pure polymorphs. Fig. 3 
showed the FT-Raman spectra of Lamivudine Form II in Form I mixture 
containing 6 % (w/w) which was studied by grinding it at different time 
intervals of 5, 10, 15, and 30 min. Similarly, Fig. 4 showed the FT-Raman 
spectra of Form I, Form II and a mixture containing 4% (w/w) of Form 
II, and Raman band observed at 798 cm-1 is the characteristic of Form II 
found in polymorphic mixture containing 4% (w/w) of Form II in Form 
I. It may be noted that this method used in this quantification work 
has been optimized in such a way that is found to be more sensitive 
to quantify Form II content in Lamivudine Form I leading to the lower 
detection levels [15].
Based on the above experimental results for Lamivudine Form II in 
Form I, FT-Raman spectroscopy was again used for the identification of 
Finasteride polymorphic mixtures [16]. It is observed from Fig. 5 that 
the Raman shifts between the two forms were clearly distinguishable. 
Later, the Raman spectra for Form I, Form II, and placebo were 
studied and shown in Fig. 6. The two polymorphic forms show a clear 
remarkable difference in the region between l750 and l550 cm-1. No 
placebo interference was observed in this region and therefore this 
region is suitable for identification and detection of the polymorphic 
forms of Finasteride. The characteristic peaks of the polymorph Form 
I were present at 1670 and l695 cm-1 and for the polymorph Form II 
at about l656 and 1677 cm-1. The peak at l598 cm-1 was common for 
Finasteride polymorphic forms [16]. This study showed that the FT-
Raman spectroscopic method is useful to detect the very low level of 
Finasteride polymorph Form II in polymorph Form I even though the 
drug concentration is less. This method might be employed for routine 
analysis for observing the polymorph changes during the formulation 
preparation and drug product.
There were several reports published for the identification and 
detection of polymorphic forms in pharmaceutical products using 
FT-Raman spectroscopy. To discuss few examples here, Roberts et al. 
studied the FT-Raman spectroscopic method for the quantification of 
a binary mixture containing beta and delta mannitol [19]. Usually, the 
polymorphic excipient of the mannitol is its beta form while the other 
alpha and delta polymorphs are the contaminants. Using this technique, 
the authors quantified up to the concentration levels down to 2% of 
the beta form. Another research group demonstrated the quantitative 
determination of polymorphic mixtures of calcium carbonate, that is, 
vaterite, aragonite, and calcite [20]. Amado et al. studied the vapor 
phase induced hydrate-anhydrate pseudopolymorphic transformations 
of theophylline crystals using a vibrational spectroscopic technique, 
that is, Raman spectroscopy [8]. Niclosamide is the antihelmintic as 
well as anti-cancer drug crystallizes into three solvated forms, that is, 
two monohydrates (NHa and NHb) and one anhydrous (NAn) form [7]. 
Here, the authors evaluated and compared the application of Raman, 
near infrared (IR), and mid-IR spectroscopy in identification and 
quantification of the polymorphic forms of niclosamide. Besides, several 
reviews highlighted the advantages of Raman spectroscopic method in 
the analysis of polymorphism in various pharmaceuticals [1,6].
CONCLUSION
Earlier days, the analysis of pharmaceuticals using Raman spectroscopy 
was limited because the technique had limitations with regard to 
sensitivity, fluorescence, and sub-sampling. Fortunately, these problems 
have been alleviated after its advancement through the development of 
FT-Raman spectrometer with charge coupled device, surface-enhanced 
Raman scattering, and transmission Raman geometry. Afterward, 
Raman spectroscopy has become notorious technique from the past 
three decades and has found incredible application in the analysis of 
environmental and biological samples, including pharmaceuticals. 
Further, it is important to mention here that the poor Raman scattering 
property of water makes the technique more superior than IR 
spectroscopy for the analysis of APIs in formulations especially when 
the drug concentration is low [1]. More importantly, the detection of 
polymorphism in the final dosage form using FT-Raman spectroscopic 
method is highly recommended due to (i) very little sample is required 
for analysis, (ii) ease of sample preparation, (iii) Raman spectra showed 
invariably sharp, well resolved bands, and (iv) Raman spectroscopy 
does not suffer from the sampling problems that are common in X-ray 
powder diffraction. Evidently, here in this paper, we have investigated 
and compared the polymorphism in Lamivudine and Finasteride 
drug substances using FT-Raman spectroscopic method at very low 
concentration level.
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